Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3Mixtatin vs MTA in Primary Molar Pulpotomy
NCT06478940Phase 1Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of metronidazole, cefixime, ciprofloxacin and simvastatin in pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Clinical success at 12 months. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
metronidazolecefiximeciprofloxacinsimvastatin
03
Conditions
pulpitis
Beyond the preview
Go deeper on NCT06478940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06478940.